OLT-2 Antibody (2564C) [Janelia Fluor® 669]
Novus Biologicals, part of Bio-Techne | Catalog # FAB10059JF669
Recombinant Monoclonal Antibody.
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-ready, Flow Cytometry
Label
Janelia Fluor 669
Antibody Source
Recombinant Monoclonal Rabbit IgG Clone # 2564C
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Chinese hamster ovary cell line CHO-derived recombinant human OLT-2/TARM-1
Met1-Val235
Accession # B6A8C7
Met1-Val235
Accession # B6A8C7
Specificity
Detects human OLT-2/TARM-1 in direct ELISAs.
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG
Applications for OLT-2 Antibody (2564C) [Janelia Fluor® 669]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
0
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: OLT-2/TARM1
Long Name
T-cell-interacting Activating Receptor on Myeloid Cells 1
Alternate Names
OLT2, TARM1
Additional OLT-2/TARM1 Products
Product Documents for OLT-2 Antibody (2564C) [Janelia Fluor® 669]
Product Specific Notices for OLT-2 Antibody (2564C) [Janelia Fluor® 669]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...